XML 43 R31.htm IDEA: XBRL DOCUMENT v3.25.3
Segment Reporting (Tables)
9 Months Ended
Sep. 30, 2025
Segment Reporting [Abstract]  
Schedule of Selected Financial Information of Reportable Segments
Selected financial information, including significant segment expenses, for our reportable segment is as follows (in millions):
Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
Net operating revenues$1,477.5 $1,351.0 $4,390.6 $3,968.2 
Less:
Salaries and benefits784.8 732.1 2,314.8 2,144.2 
Other operating expenses229.2 201.8 660.0 584.9 
Occupancy costs14.9 14.4 44.5 42.6 
Supplies64.6 60.6 189.9 176.7 
General and administrative expenses39.6 39.1 124.6 114.3 
Net income attributable to noncontrolling interests48.1 38.9 135.9 104.9 
Other segment items(1)
(3.8)(5.2)(11.4)(13.5)
Adjusted EBITDA$300.1 $269.3 $932.3 $814.1 
(1)Includes interest and dividend income, investment gain or loss, and equity in net income of nonconsolidated affiliates.
Reconciliation of Segment Adjusted EBITDA to Income from Continuing Operations Before Income Tax Expense
Segment reconciliation (in millions):
Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
Adjusted EBITDA$300.1 $269.3 $932.3 $814.1 
Stock-based compensation(14.3)(12.9)(38.1)(35.8)
Depreciation and amortization(82.4)(78.4)(241.5)(221.6)
Loss on disposal or impairment of assets(1.9)(0.6)(2.4)(11.3)
Loss on early extinguishment of debt— (0.4)— (0.4)
Interest expense and amortization of debt discounts and fees(30.8)(34.9)(93.0)(104.4)
Net income attributable to noncontrolling interests48.1 38.9 135.9 97.6 
Change in fair market value of marketable securities1.1 2.8 2.1 2.7 
Asset impairment impact on noncontrolling interests— — — 7.3 
Income from continuing operations before income tax expense$219.9 $183.8 $695.3 $548.2 
Reconciliation of Revenue from Segments to Consolidated
Additional detail regarding the revenues of our operating segment by service line follows (in millions):
Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
Net operating revenues:
Inpatient$1,427.3 $1,316.2 $4,258.7 $3,864.4 
Outpatient and other50.2 34.8 131.9 103.8 
Net operating revenues$1,477.5 $1,351.0 $4,390.6 $3,968.2